siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma (Q40035650)

From Wikidata
Jump to navigation Jump to search
scientific article published on 13 December 2007
edit
Language Label Description Also known as
English
siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
scientific article published on 13 December 2007

    Statements

    siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma (English)
    1 reference
    Massimo Santoro
    1 reference
    13 December 2007
    1 reference
    36
    1 reference
    1
    1 reference
    e2
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit